Registry

Oral Cancer :: USC School of Dentistry researchers discover link between oral cancer and ethnicity

Clinicians from the USC School of Dentistry unravel connection between the incidence of oral cancer and race and ethnicity– as part of first epidemiological study of oral cancer in California. Dr. Satish Kumar and Dr.Parish Sedghizadeh, clinical professors in the school’s Division of Diagnostic Sciences, gleaned through 20 years of records from the California Cancer Registry (CCR)—the state’s cancer surveillance database—for the incidence rates of invasive squamous cell carcinoma, the most common form of oral cancer.

HIV :: FDA approves new HIV drug raltegravir tablets

The U.S. Food and Drug Administration (FDA) has approved raltegravir tablets for treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.

Gastroenterology :: Study measures impact on productivity from functional gastrointestinal disorders

Those who suffer from common functional gastrointestinal disorders face work productivity losses and impairments in daily activity that amount to the loss of at least one day of work in a 40-hour workweek, according to a new study presented at the Annual Scientific Meeting of the American College of Gastroenterology.

Colorectal Cancer :: Colorectal cancer screening remains essential for elderly Americans

As people get older, their risk of developing polyps and colorectal cancer increases. Currently, there is no clear evidence or established guideline for the upper age limit for colorectal cancer screening by colonoscopy. Two new studies presented at the American College of Gastroenterology’s 72nd Annual Scientific Meeting suggest continued colorectal cancer screening among healthy elderly Americans.

Prostate Cancer :: Surgery may offer best chance of long-term prostate cancer survival

A study from Switzerland suggests that men who have surgery for prostate cancer appear less likely to die of the disease within 10 years than men who choose other treatment options, especially if they are younger or have cancers with certain tumor cell characteristics, according to a report in the Oct. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.